395
Participants
Start Date
February 26, 2013
Primary Completion Date
October 5, 2016
Study Completion Date
October 5, 2016
Data collection
HZ/PHN booklet, HZ/PHN file and logbook. HZ/PHN booklet will be completed by the patient and the HZ/PHN file and logbook will be completed by the participating general practitioner.
GSK Investigational Site, Oviglio (AL)
GSK Investigational Site, Sale (AL)
GSK Investigational Site, Villalvernia (AL)
GSK Investigational Site, Frugarolo (AL)
GSK Investigational Site, Alessandria
GSK Investigational Site, Sesto Calende (VA)
GSK Investigational Site, Comerio (VA)
GSK Investigational Site, Ghirla Valganna (VA)
GSK Investigational Site, Induno Olona (VA)
GSK Investigational Site, Arcisate (VA)
GSK Investigational Site, Solbiate Olona (VA)
GSK Investigational Site, Fagnano Olona (VA)
GSK Investigational Site, Varese
GSK Investigational Site, Lucignano (AR)
GSK Investigational Site, Arezzo
GSK Investigational Site, Orbetello (GR)
GSK Investigational Site, Follonica (GR)
GSK Investigational Site, Sassofortino (GR)
GSK Investigational Site, Arcidosso (GR)
GSK Investigational Site, Civitella Paganico (GR)
GSK Investigational Site, Grosseto
GSK Investigational Site, Galatina (LE)
GSK Investigational Site, Cavallino (LE)
GSK Investigational Site, Cutrofiano (LE)
GSK Investigational Site, Montesano S. (LE)
GSK Investigational Site, Specchia (LE)
GSK Investigational Site, Copertino (LE)
GSK Investigational Site, Parabita (LE)
GSK Investigational Site, Napoli
GSK Investigational Site, Napoli
GSK Investigational Site, Rome
GSK Investigational Site, Rome
GSK Investigational Site, Rome
GSK Investigational Site, Rome
GSK Investigational Site, Rome
GSK Investigational Site, Rome
GSK Investigational Site, Rome
GSK Investigational Site, Angera (VA)
GSK Investigational Site, Perugia
GSK Investigational Site, Alessano (LE)
GSK Investigational Site, Perugia
GSK Investigational Site, Perugia
GSK Investigational Site, Ripa (PG)
Lead Sponsor
GlaxoSmithKline
INDUSTRY